Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women

Annals of Vascular Surgery

Volumn 26, Issue 3, 2012, Pages 411-418

  Rockman, Caron B ^a   Maldonado, Thomas S ^a   Jacobowitz, Glenn R ^a   Adelman, Mark A ^a   Riles, Thomas S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CIGARETTE SMOKING; COMORBIDITY; DATA BASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE; RISK FACTOR; SCREENING TEST;

AGE FACTORS; AGED; ANKLE BRACHIAL INDEX; CHI-SQUARE DISTRIBUTION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; POSTMENOPAUSE; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84858448835     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2011.10.012     Document Type: Article

References (32)

1. A.B. Newman, D.S. Siscovick, T.A. Manolio Cardiovascular Heart Study (CHS) Collaborative Research Group Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study Circulation 88 1993 837 845
2. G. Greco, N.N. Egorova, and A.C. Gelijns Development of a novel scoring tool for the identification of large >/=5 cm abdominal aortic aneurysms Ann surg 252 2010 675 682
3. K.C. Kent, R.M. Zwolak, and N.N. Egorova Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals J Vasc Surg 52 2010 539 548
4. A.K. Vavra, and M.R. Kibbe Women and peripheral arterial disease Womens health (Lond Engl) 5 2009 669 683
5. G. Brevetti, R. Bucur, and A. Balbarini Women and peripheral arterial disease: same disease, different issues J Cardiovasc Med (Hagerstown) 9 2008 382 388
6. A.G. Vouyouka, and K.C. Kent Arterial vascular disease in women J vasc surg 46 2007 1295 1302
7. J.P. Higgins, and J.A. Higgins Epidemiology of peripheral arterial disease in women J Epidemiol 13 2003 1 14
8. M.T. Vogt, J.A. Cauley, L.H. Kuller, and S.B. Hulley Prevalence and correlates of lower extremity arterial disease in elderly women Am J Epidemiol 137 1993 559 568
9. M.T. Vogt, S.K. Wolfson, and L.H. Kuller Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality J Clin Epidemiol 46 1993 1267 1276
10. W.T. Meijer, D.E. Grobbee, M.G. Hunink, A. Hofman, and A.W. Hoes Determinants of peripheral arterial disease in the elderly: the Rotterdam study Arch Intern Med 160 2000 2934 2938
11. E.F. Bernstein, and A. Fronek Current status of noninvasive tests in the diagnosis of peripheral arterial disease Surg Clin North Am 62 1982 473 487
12. P. Greenland, J. Abrams, and G.P. Aurigemma Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: writing group III Circulation 101 2000 E16 E22
13. M.H. Criqui, R.D. Langer, and A. Fronek Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
14. F.R. Rosendaal, A. Van Hylckama Vlieg, B.C. Tanis, and F.M. Helmerhorst Estrogens, progestogens and thrombosis. Journal of thrombosis and haemostasis J Thromb Haemost 1 2003 1371 1380
15. L. Mosca, L.J. Appel, and E.J. Benjamin Evidence-based guidelines for cardiovascular disease prevention in women Circulation 109 2004 672 693
16. A. Thijs, and C.D. Stehouwer Changes of hemostatic variables during hormone replacement therapy Semin Vasc Med 3 2003 85 92
17. R.S. Davies, R.K. Vohra, A.W. Bradbury, and D.J. Adam The impact of hormone replacement therapy on the pathophysiology of peripheral arterial disease Eur J Vasc Endovasc Surg 34 2007 569 575
18. H.N. Hodis, W.J. Mack, and R.A. Lobo Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial Ann Intern Med 135 2001 939 953
19. I.C. Westendorp, M.J. de Kleijn, and M.L. Bots The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial Atherosclerosis 152 2000 149 157
20. R.H. Mackey, L.H. Kuller, and K. Sutton-Tyrrell Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study Arch Intern Med 165 2005 510 515
21. A.A. Nabulsi, A.R. Folsom, and M. Szklo No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators Circulation 94 1996 1857 1863
22. I.C. Westendorp, B.A. in't Veld, and D.E. Grobbee Hormone replacement therapy and peripheral arterial disease: the Rotterdam study Arch Intern Med 160 2000 2498 2502
23. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
24. N. Cherry, K. Gilmour, and P. Hannaford Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial Lancet 360 2002 2001 2008
25. J. Hsia, J.A. Simon, and F. Lin Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study Circulation 102 2000 2228 2232
26. D. Grady, D. Herrington, and V. Bittner Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
27. J. Hsia, M.H. Criqui, and R.J. Rodabough Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative Circulation 109 2004 620 626
28. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
29. J. Hsia, M.H. Criqui, and D.M. Herrington Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative Am Heart J 152 2006 170 176
30. J.J. Belch Metabolic, endocrine and haemodynamic risk factors in the patient with peripheral arterial disease Diabetes Obes Metab 4 Suppl. 2 2002 S7 S13
31. C.H. Timaran, S.L. Stevens, and O.H. Grandas Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting J Vasc Surg 32 2000 506 516 discussion 16-8
32. C.H. Timaran, S.L. Stevens, O.H. Grandas, M.B. Freeman, and M.H. Goldman Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting J Vasc Surg 33 2001 S85 S92